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Introduction: Elevated arginine vasopressin (AVP) levels are associated with poor prognosis in cardiac and non-cardiac diseases. Copeptin, a 
fragment of pre-pro-vasopression, is a stable surrogate biomarker for AVP.
Methods: In this secondary analysis of the Biomarkers in Acute Heart Failure (BACH) study, the prognostic utility of copeptin was evaluated in 525 
patients with acute dyspnea due to chronic obstructive pulmonary disease, asthma, bronchitis, pneumonia, and influenza.
Results: There were 26 deaths within 90 days. Copeptin was a strong univariate predictor of mortality (HR=9.653, p<0.001). The AUC for copeptin 
was 0.802, p<0.001. The ROC derived cutpoint for copeptin was 26.2pmol/L. Patients in the high copeptin subgroup had significantly increased 
mortality (p<0.001). (Figure) In a stepwise multivariate model, copeptin was a significant predictor of mortality (HR=3.143 p=0.026), independent 
of other significant clinical predictors [systolic blood pressure (SBP), black race, respiratory rate (RR) and renal insufficiency (CRI)]. Adding copeptin 
to a model consisting of SBP, RR, black race and CRI increased the C-statistic from 0.788 to 0.849 (p<0.001). In multivariate analysis with SBP, RR 
and CRI, elevated copeptin was a significant independent predictor of prolonged hospital stay (>5 days) (HR=3.22, P<0.001).
Conclusions: Copeptin is a significant independent predictor of mortality and prolonged hospital stay in patients with acute dyspnea due to non-
cardiac causes.
 
